Grossberg, G. T., Manes, F. F., Allegri, R. F., Gutiérrez Robledo, L. M., Gloger, S., Xie, L., . . . Graham, S. M. (2013). The safe, tolerability, and efficacy of once-daily memantine (28mg): A multinational, randomized, placebo-controlled trial in patients with moderate to severe Alzheimer's disease taking cholinesterase inhibitor. Web
Citación estilo ChicagoGrossberg, George T., et al. The Safe, Tolerability, and Efficacy of Once-daily Memantine (28mg): A Multinational, Randomized, Placebo-controlled Trial in Patients With Moderate to Severe Alzheimer's Disease Taking Cholinesterase Inhibitor. 2013.
Cita MLAGrossberg, George T., et al. The Safe, Tolerability, and Efficacy of Once-daily Memantine (28mg): A Multinational, Randomized, Placebo-controlled Trial in Patients With Moderate to Severe Alzheimer's Disease Taking Cholinesterase Inhibitor. 2013.